A clinician's view of the molecular genetics of age-related maculopathy

被引:26
作者
Gorin, Michael B.
机构
[1] Jules Stein Eye Inst, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[4] Univ Pittsburgh, Med Ctr, Grad Sch Publ Hlth, Ctr Eye, Pittsburgh, PA USA
关键词
COMPLEMENT FACTOR-H; MACULAR DEGENERATION; APOLIPOPROTEIN-E; DIETARY-FAT; CIGARETTE-SMOKING; NATIONAL-HEALTH; VITAMIN-E; ASSOCIATION; DISEASE; RISK;
D O I
10.1001/archopht.125.1.21
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Molecular genetic studies of age-related maculopathy (ARM), including family-based linkage studies and case-control association studies, have yielded valuable insights into the risks of developing this condition and potential disease-causing mechanisms. Variants in the complement factor H gene and LOC387715 have consistently been shown to be major risk factors for ARM. Additional genes, and environmental, behavioral, and dietary factors, also play a major role in ARM pathogenesis. The present studies are a starting point toward our understanding of the causes of ARM and for future therapeutic studies. As clinicians, we can already begin to use our knowledge of ARM genetics to counsel and care for our patients at risk.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 65 条
[1]   Heterogeneity of the genetic risk in age-related macular disease - A population-based familial risk study [J].
Assink, JJM ;
Klaver, CCW ;
Houwing-Duistermaat, JJ ;
Wolfs, RCW ;
van Duijn, CM ;
Hofman, A ;
de Jong, PTVM .
OPHTHALMOLOGY, 2005, 112 (03) :482-487
[2]   Age-related macular degeneration and nutritional supplementation: a review of randomised controlled trials [J].
Bartlett, H ;
Eperjesi, F .
OPHTHALMIC AND PHYSIOLOGICAL OPTICS, 2003, 23 (05) :383-399
[3]   Age-related macular degeneration: economic burden and value-based medicine analysis [J].
Brown, MM ;
Brown, GC ;
Stein, JD ;
Roth, Z ;
Campanella, J ;
Beauchamp, GR .
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2005, 40 (03) :277-287
[4]   Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients [J].
Cardinault, N ;
Abalain, JH ;
Sairafi, B ;
Coudray, C ;
Grolier, P ;
Rambeau, M ;
Carré, JL ;
Mazur, A ;
Rock, E .
CLINICA CHIMICA ACTA, 2005, 357 (01) :34-42
[5]   Vitamin E and the age-related eye disease study supplementation for age-related macular degeneration [J].
Chew, EY ;
Clemons, T .
ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (03) :395-396
[6]   ANTIOXIDANTS AND EYE DISEASE [J].
CHRISTEN, WG .
AMERICAN JOURNAL OF MEDICINE, 1994, 97 :S14-S17
[7]   Polypoidal choroidal vasculopathy [J].
Ciardella, AP ;
Donsoff, IM ;
Huang, SJ ;
Costa, DL ;
Yannuzzi, LA .
SURVEY OF OPHTHALMOLOGY, 2004, 49 (01) :25-37
[8]   Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy [J].
Conley, YP ;
Thalamuthu, A ;
Jakobsdottir, J ;
Weeks, DE ;
Mah, T ;
Ferrell, RE ;
Gorin, MB .
HUMAN MOLECULAR GENETICS, 2005, 14 (14) :1991-2002
[9]  
CONLEY YP, IN PRESS HUM MOL GEN
[10]   Age-related macular degeneration and its possible prevention [J].
Constable, LJ .
MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (09) :471-472